Targeting Epigenetics in Lung Cancer
Authors:
- 8 September 2020
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 11 (6) , a038000
Abstract
The epigenetic landscape, which in part includes DNA methylation, chromatin organization, histone modifications, and noncoding RNA regulation, greatly contributes to the heterogeneity that makes developing effective therapies for lung cancer challenging. This review will provide an overview of the epigenetic alterations that have been implicated in all aspects of cancer pathogenesis and progression as well as summarize clinical applications for targeting epigenetics in the treatment of lung cancer.Keywords
This publication has 184 references indexed in Scilit:
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell linesCell Death & Disease, 2013
- The significance of epigenetic alterations in lung carcinogenesisMolecular Biology Reports, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- RNA interference in the clinic: challenges and future directionsNature Reviews Cancer, 2010
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21Cancer Cell, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- DNA methylation patterns in lung carcinomasSeminars in Cancer Biology, 2009
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- MicroRNA expression profiles classify human cancersNature, 2005
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002